Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Gastroenterology. 2021 Jul 19;161(5):1433–1442.e2. doi: 10.1053/j.gastro.2021.07.012

Table 3.

The Accuracy of PyloriAR Next-Generation Sequencing in Determining the Antibiotic Resistance of Helicobacter pylori in Formalin-Fixed, Paraffin-Embedded Tissues

Antibiotics PyloriAR NGS, FFPE results Culture (MIC)
Sensitivity, % Specificity, % Predictive value, %
Accuracy, % Agreement, k coefficient
(+) (−) PPV NPV

Clarithromycin (+) 28 8
 Total n = 170 (−) 2 132 93.3 94.3 77.8 98.5 94.1 0.81236 (P < .0001)
 95% CI 77.9–99.2 89–97.5 63.9–87.3 94.5–99.6 89.4–97.1 0.70076 to 0.92396
Amoxicillin (+) 1 0
 Total n = 170 (−) 7 162 12.5 100 100 95.9 95.9 0.21400 (P = .0051)
 95% CI 0.3–52.6 97.7–100.0 94.7–96.8 91.7–98.3 −0.13849 to 0.56649
Metronidazole (+) 68 10
 Total n = 170 (−) 29 63 70.1 86.3 87.2 68.5 77.1 0.54645 (P < .0001)
 95% CI 60–79 76.2–93.2 79–92.5 61.2–74.9 70.0–83.1 0.42443 to 0.66847
Rifabutin (+) 0 0
 Total n = 170 (−) 0 170 100.0 100.0
 95% CI 97.8–100.0
Levofloxacin (+) 29 3
 Total n = 57 (−) 4 21 87.9 87.5 90.6 84.0 87.7 0.74953 (P < .0001)
 95% CI 71.8–96.6 67.6–97.3 76.9–96.6 67.4–93 76.3–94.9 0.57597 to 0.92308
Tetracycline (+) 0 0
 Total n = 57 (−) 1 56 0.0 100.0 98.2 98.2
 95% CI 0.0–97.5 93.6–100.0 98.2–98.2 90.6–100

(+), resistant; (−), sensitive; CI, confidence interval.